Systematic analysis of the median survival time (MST), time to reach endpoint (TTE), tumour growth delay (TGD), and increased live span (ILS) corroborated the therapeutic potential of Epacasome-2 + α-PD-1 (Supplementary Table 1). The gene discussed is PDCD1; the disease is neoplasm.